Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions - Additional Information (Detail)

v3.10.0.1
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 27, 2016
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
ProBiora Health, LLC [Member] | Discontinued Operations Disposed of by Sale [Member]              
Related Party Transaction [Line Items]              
Sales price of business $ 1,700,000            
Cash received from sale of business 1,250,000            
Receivable from sale of business $ 450,000            
Interest rate 1.00%            
Contingent consideration payment period 10 years            
Contingent consideration           $ 0 $ 0
ProBiora Health, LLC [Member] | Discontinued Operations Disposed of by Sale [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Contingent consideration $ 2,000,000            
Intrexon [Member] | Oral Mucositis and Lantibiotic Exclusive Channel Collaboration Agreements [Member]              
Related Party Transaction [Line Items]              
Cash paid to Intrexon Corporation   $ 89,216 $ 0 $ 159,233 $ 524,620    
Accounts payable and accrued expenses   $ 142,333   $ 142,333   $ 39,457  
Principal Owner [Member] | Intrexon [Member]              
Related Party Transaction [Line Items]              
Percentage of outstanding common stock   25.40% 31.40% 25.40% 31.40%